Tue. 28 May 2024, 7:06am ET
Benzinga
Biotech, Earnings, News, Guidance, Health Care, General
The company says this amount does not include $6.0 million in gross proceeds received from a registered direct offering and a $20.0 million drawdown of the second tranche from the existing loan agreement with BlackRock, which were both completed in April 2024.